RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (“Rotech”), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash.

弗吉尼亚州里士满——（商业新闻短讯）——欧文斯美诺公司（Owens＆Minor，Inc.）（纽约证券交易所代码：OMI）今天宣布，它已签署最终协议，以13.6亿美元现金收购总部位于佛罗里达州奥兰多的私人家庭护理业务Rotech Healthcare Holdings，Inc.（“Rotech”）。

Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple of LTM EBITDA, excluding synergies..

鉴于交易产生的预期税收优惠约为4000万美元，净收购价格约为13.2亿美元，约为LTM息税折旧摊销前利润（不包括协同效应）的6.3倍。

Rotech is a national leader in providing home medical equipment in the United States. The company has over 4,200 employees and provides products and services in 46 states through approximately 325 operating locations. Rotech generated approximately $750 million of revenue and an EBITDA margin of nearly 30% in 2023..

Rotech是美国国内领先的家用医疗设备供应商。该公司拥有4200多名员工，通过大约325个营业点在46个州提供产品和服务。2023年，Rotech产生了约7.5亿美元的收入，息税折旧摊销前利润率接近30%。

“Rotech squarely fits into our existing Patient Direct segment and directly aligns with the strategy we outlined last December during our Investor Day, supporting our expansion in the very large and fast-growing home-based care space. We are excited to acquire a high-quality company like Rotech, an opportunity that doesn’t come along very often, and I look forward to welcoming the Rotech teammates into the Owens & Minor family,” said Edward A.

Edward a.表示：“Rotech完全符合我们现有的直接患者细分市场，并与我们去年12月在投资者日期间概述的战略直接一致，支持我们在非常庞大且快速增长的家庭护理领域的扩张。我们很高兴收购像Rotech这样的高质量公司，这是一个不常出现的机会，我期待着欢迎Rotech的队友加入Owens&Minor家族。”

Pesicka, President & Chief Executive Officer of Owens & Minor..

佩西卡，Owens&Minor总裁兼首席执行官。

Pesicka added, 'This transaction highlights our disciplined approach toward inorganic growth, with a focus on strategic fit, value creation for shareholders, prudent capital allocation and most importantly, providing improved service and experience to patients, providers, and payors. Furthermore, we are committed to deleveraging the balance sheet to below 3.0x in approximately 24 months after closing.”.

佩西卡补充说，“这项交易突显了我们对无机增长的严格方法，重点是战略匹配、为股东创造价值、审慎的资本分配，最重要的是，为患者、提供者和付款人提供改进的服务和经验。此外，我们承诺在交割后约24个月内将资产负债表去杠杆化至3.0倍以下。”

“The team and I look forward to being part of Owens & Minor due to their commitment to providing best-in-class products and services to patients in their homes. Owens & Minor is a natural home for the Rotech team, and we believe the combination will benefit patients, providers, payors, and employees,” said Robin Menchen, President & Chief Executive Officer of Rotech..

Rotech总裁兼首席执行官罗宾·门辰（Robin Menchen）表示：“欧文斯和米诺致力于为家中的患者提供一流的产品和服务，因此，我和团队期待成为欧文斯和米诺的一员。欧文斯和米诺是Rotech团队的天然家园，我们相信这一组合将使患者、提供者、付款人和员工受益。”

Strategic Rationale

战略依据

Strengthens Patient Direct product offerings through expansion across a complementary portfolio including Respiratory, Sleep Apnea, Diabetes, Wound Care, and provides access to the Durable Medical Equipment (DME) market.

通过扩展包括呼吸、睡眠呼吸暂停、糖尿病、伤口护理在内的互补产品组合，加强患者直接提供的产品，并提供进入耐用医疗设备（DME）市场的途径。

Supports combined customer base allowing Owens & Minor to better serve providers and payors across an integrated national network.

支持综合客户群，使Owens&Minor能够在一个综合的全国网络中更好地为提供商和付款人服务。

Enables Owens & Minor to more comprehensively serve patients through the combined suite of complementary product offerings and improved service for patients with chronic conditions in large and fragmented markets.

使欧文斯美诺能够通过一整套补充产品产品为患者提供更全面的服务，并在大型和分散的市场中为慢性病患者提供更好的服务。

Provides significant synergy opportunity of approximately $50 million by the end of year three, with further upside potential, as well as prospect for additional revenue synergies in both the near and long term.

在第三年年底前提供约5000万美元的重大协同机会，具有进一步的上行潜力，并有望在近期和长期实现额外的收入协同。

Accelerates the growth path for the Patient Direct segment as outlined at the December 2023 Investor Day to achieve $5 billion in revenue by 2028.

如2023年12月投资者日所述，加速患者直接细分市场的增长路径，到2028年实现50亿美元的收入。

Transaction Details

交易详细信息

Under the terms of the agreement, which was unanimously approved by the Board of Directors of each company, Owens & Minor will acquire Rotech for $1.36 billion in an all-cash transaction. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion.

根据经每家公司董事会一致批准的协议条款，欧文斯美诺将以13.6亿美元的全现金交易收购Rotech。鉴于交易产生的预期税收优惠约为4000万美元，净收购价格约为13.2亿美元。

Owens & Minor has fully committed financing in place and expects to use a combination of cash and incremental borrowings to fund the purchase price. At closing, Owens & Minor is expected to have book leverage of approximately 4.2x and expects to de-lever below 3.0x book leverage in approximately 24 months of closing..

Owens&Minor已完全承诺融资，预计将使用现金和增量借款相结合的方式为购买价格提供资金。收盘时，欧文斯美诺的账面杠杆率预计约为4.2倍，预计在收盘后约24个月内，账面杠杆率将降至3.0倍以下。

The transaction is subject to customary closing conditions, including the Hart Scott Rodino Act, and is expected to close by the end of 2024.

该交易受制于惯例成交条件，包括《哈特-斯科特-罗迪诺法案》，预计将于2024年底完成。

Citi acted as exclusive financial advisor to Owens & Minor in connection with this acquisition. Owens & Minor’s legal advisor is Kirkland & Ellis LLP.

花旗在此次收购中担任欧文斯美诺的独家财务顾问。Owens&Minor的法律顾问是Kirkland&Ellis LLP。

Jefferies LLC acted as exclusive financial advisor to Rotech in connection with the acquisition. Rotech’s legal advisor is Paul, Weiss, Rifkind, Wharton & Garrison LLP.

Jefferies LLC担任Rotech收购的独家财务顾问。Rotech的法律顾问是Paul，Weiss，Rifkind，Wharton&Garrison LLP。

Conference Call Information

电话会议信息

Owens & Minor will host a conference call at 8:30 a.m. EDT today to discuss the transaction. Participants may access the call at 877-407-8037. The international dial-in number is 1-201-689-8037. A webcast of the event will be available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above..

欧文斯美诺公司将于美国东部时间今天上午8:30召开电话会议，讨论这笔交易。参与者可以拨打877-407-8037。国际拨入号码是1-201-689-8037。此次活动的网络直播将在investors.owens minor.com/events and presentations/上进行。演示结束后，可以通过上面提供的链接访问网络广播的重播。

Safe Harbor

安全港

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

本次发布旨在通过合理设计的方法进行披露，以按照美国证券交易委员会的公平披露法规向公众提供广泛的非排他性分发。本新闻稿包含根据1995年《私人证券诉讼改革法案》安全港条款做出的某些“前瞻性”声明。

Some of these statements can be identified by terms and phrases such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words.

其中一些陈述可以通过术语和短语来识别，例如“展望”，“相信”，“期望”，“潜在”，“继续”，“可能”，“将”，“应该”，“可能”，“寻求”，“预测”，“打算”，“趋势”，“计划”，“估计”，“预期”或这些单词或其他类似单词的负面版本。

These statements include, but are not limited to, the statements in this release regarding the proposed transaction and opportunities related thereto, Owens & Minor’s expectations with respect to its financial performance and expectations of its business. Forward-looking statements involve known and unknown risks and uncertainties that may cause Owens & Minor’s actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements, including the occurrence of any event, change or other circumstances that could give rise to the termination of the agreement relating to the proposed transaction; risks related to disruption of management’s attention from Owens & Minor’s ongoing business operations due to the proposed transaction; the effect of the announcement of the proposed transaction on Owens & Minor’s or Rotech’s relationships with its customers, suppliers and other third parties, as well as it operating results and business generally; the risk that the proposed transaction will not be consummated in a timely manner; exceeding the expected costs of the transac.

这些声明包括但不限于本新闻稿中有关拟议交易和相关机会的声明，欧文斯美诺对其财务业绩的期望以及对其业务的期望。前瞻性陈述涉及已知和未知的风险和不确定性，这些风险和不确定性可能导致欧文斯美诺在未来期间的实际业绩与前瞻性陈述中预测或预期的结果存在重大差异，包括发生任何可能导致与拟议交易有关的协议终止的事件、变化或其他情况；由于拟议交易，管理层对欧文斯美诺正在进行的业务运营的关注受到干扰；宣布拟议交易对Owens&Minor或Rotech与其客户、供应商和其他第三方的关系以及it运营结果和业务的影响；拟议交易无法及时完成的风险；超过交易的预期成本。

About Owens & Minor

关于Owens&Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve.

Owens&Minor，Inc.（纽约证券交易所代码：OMI）是一家财富500强全球医疗保健解决方案公司，提供从医院到家庭的基本产品和服务。100多年来，欧文斯美诺及其附属品牌Apria®、Byram®和HALYARD*，帮助我们服务的患者、提供者和社区每天都过得更好。

Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram..

在全球20000多名队友的支持下，Owens&Minor在幕后提供了舒适和自信，因此医疗保健始终处于领先地位。Owens&Minor的存在是因为每天，无论在哪里，生活都会照顾到你。有关Owens&Minor及其附属品牌的更多信息，请访问Owens-Minor.com或在LinkedIn和Instagram上关注我们。

*Registered Trademark or Trademark of O&M Halyard or its affiliates.

*运维Halyard或其关联公司的注册商标或商标。

About Rotech

关于Rotech

Rotech is one of the largest providers of home medical equipment and related products and services (collectively referred to as “HME products and services”) in the United States, with a comprehensive offering of oxygen, other respiratory therapy equipment, wound care equipment and supplies, and diabetes devices and supplies.

Rotech是美国最大的家庭医疗设备及相关产品和服务（统称为“HME产品和服务”）供应商之一，全面提供氧气、其他呼吸治疗设备、伤口护理设备和用品以及糖尿病设备和用品。

The Company provides HME products and services in 46 states through approximately 325 operating locations..

该公司通过大约325个运营地点在46个州提供HME产品和服务。